Pathological Correlation of Inflammatory Cytokines with Neurocognitive Impairment in Pediatric Epilepsy. A Clinical Cross-Sectional Study
Inflammatory Cytokines and Cognitive Decline in Pediatric Epilepsy
DOI:
https://doi.org/10.69750/dmls.02.04.0123Keywords:
Pediatric epilepsy, cognitive impairment, cytokines, IL-6, TNF-α, IL-1β, neuroinflammation, WISC-IVAbstract
Background: Pediatric epilepsy is a common neurological condition characterized not only by recurrent seizures but also by notable disruptions in cognitive development during key stages of brain maturation. Recent studies have increasingly implicated neuroinflammatory processes—particularly those involving pro-inflammatory cytokines—as major contributors to both seizure activity and cognitive deterioration. Despite this, limited clinical evidence exists regarding the relationship between systemic inflammation and cognitive outcomes in epileptic children.
Objective: This study aimed to investigate the association between serum levels of key inflammatory cytokines (IL-6, TNF-α, and IL-1β) and cognitive performance in children diagnosed with epilepsy.
Methods: Between January 2022 and March 2023, 100 pediatric epilepsy patients, ages 5 to 16, were selected from two tertiary healthcare institutions in Pakistan for a cross-sectional analysis. The Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV) was used to assess cognitive ability. TNF-α, IL-1β, and IL-6 serum concentrations were measured by the enzyme-linked immunosorbent assay (ELISA). Multivariate linear regression and Pearson's correlation were used in the statistical analysis to find correlations between cytokine levels and cognitive scores.
Results: Serum levels of IL-6 (6.2 ± 1.1 pg/mL), TNF-α (7.9 ± 1.5 pg/mL), and IL-1β (5.0 ± 1.3 pg/mL) were substantially greater in participants with impaired cognitive function (Full Scale IQ < 85) than in those with normal cognitive function (p < 0.001). IL-6 and Full-Scale IQ showed a considerable negative connection (r = –0.65, p < 0.001), with the Processing Speed Index being most affected. While IL-1β was particularly associated with working memory problems, multivariate regression revealed that IL-6 and TNF-α were independent predictors of worse cognitive scores.
Conclusion: Systemic inflammation, marked by elevated cytokine levels, is significantly associated with cognitive impairment in pediatric epilepsy, independent of seizure frequency or antiepileptic medication. These findings underscore the importance of inflammatory biomarkers in predicting neurocognitive outcomes and suggest potential benefits of integrating cytokine assessment into routine clinical evaluation to identify high-risk patients and explore anti-inflammatory treatment strategies.
Downloads
References
Bartolini L, Moran MP, Norato G, Thomas B, Dick AD, Wells E, et al. Differential activation of neuroinflammatory pathways in children with seizures: A cross-sectional study. Seizure. 2021;91:150-8.doi: https://doi.org/10.1016/j.seizure.2021.05.022
Arend J, Kegler A, Caprara ALF, Almeida C, Gabbi P, Pascotini ET, et al. Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy. Epilepsy & Behavior. 2018;86:49-57.doi: https://doi.org/10.1016/j.yebeh.2018.07.007
Zhao K, Chen P, Alexander-Bloch A, Wei Y, Dyrba M, Yang F, et al. A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study. eClinicalMedicine. 2023;65.doi: 10.1016/j.eclinm.2023.102276
Zervides KA, Jern A, Nystedt J, Gullstrand B, Nilsson PC, Sundgren PC, et al. Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study. BMC Rheumatology. 2022;6(1):38.doi: 10.1186/s41927-022-00268-w
McGuire JL, Gill AJ, Douglas SD, Kolson DL, group CHA-RTER. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. Journal of NeuroVirology. 2015;21(4):439-48.doi: 10.1007/s13365-015-0333-3
Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, et al. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet Neurology. 2021;20(8):615-26.doi: 10.1016/S1474-4422(21)00139-3
Zheng Y, Cai X, Wang D, Chen X, Wang T, Xie Y, et al. Exploring the relationship between lipid metabolism and cognition in individuals living with stable-phase Schizophrenia: a small cross-sectional study using Olink proteomics analysis. BMC Psychiatry. 2024;24(1):593.doi: 10.1186/s12888-024-06054-x
Colgecen E, Celikbilek A, Keskin DT. Cognitive Impairment in Patients with Psoriasis: A Cross-Sectional Study Using the Montreal Cognitive Assessment. American Journal of Clinical Dermatology. 2016;17(4):413-9.doi: 10.1007/s40257-016-0187-3
Parisi GF, Diaferio L, Brindisi G, Indolfi C, Umano GR, Klain A, et al. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children [Internet]. 2021; 8(9).doi: 10.3390/children8090769
Liu X, Ma Y, Ouyang R, Zeng Z, Zhan Z, Lu H, et al. The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome. Journal of Neuroinflammation. 2020;17(1):229.doi: 10.1186/s12974-020-01905-2
Soares JZ, Valeur J, Šaltytė Benth J, Knapskog A-B, Selbæk G, Bogdanovic N, et al. Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer’s Disease: A Cross-Sectional Study. Journal of Alzheimer’s Disease. 2022;89(3):825-34.doi: 10.3233/jad-220407
Checkouri T, Missamou F, Pion SDS, Bikita P, Hemilembolo MC, Boussinesq M, et al. Association between altered cognition and Loa loa microfilaremia: First evidence from a cross-sectional study in a rural area of the Republic of Congo. PLOS Neglected Tropical Diseases. 2023;17(6):e0011430.doi: 10.1371/journal.pntd.0011430
Chen Y, Le D, Xu J, Jin P, Zhang Y, Liao Z. Gut Microbiota Dysbiosis and Inflammation Dysfunction in Late-Life Depression: An Observational Cross-Sectional Analysis. Neuropsychiatric Disease and Treatment. 2024;20(null):399-414.doi: 10.2147/NDT.S449224
Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, et al. Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation. Journal of Geriatric Psychiatry and Neurology. 2020;33(4):175-84.doi: 10.1177/0891988719874118
Alfaki DA, Hussein M, Hassan M, Eloraish AG, Elbasheir MM. Inflammatory immune mediators and Plasmodium falciparum infection: a cross-sectional study among Sudanese patients with severe and uncomplicated malaria. Exploration of Immunology. 2023;3(4):406-15.doi: 10.37349/ei.2023.00109
Williams ME, Stein DJ, Joska JA, Naudé PJW. Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review. Journal of Neuroimmunology. 2021;358:577649.doi: https://doi.org/10.1016/j.jneuroim.2021.577649
Algul FE, Kaplan Y. Increased Systemic Immune-Inflammation Index as a Novel Indicator of Alzheimer’s Disease Severity. Journal of Geriatric Psychiatry and Neurology. 2025;38(3):214-22.doi: 10.1177/08919887241280880
Yang H, Liao Z, Zhou Y, Gao Z, Mao Y. Non-linear relationship of serum albumin-to-globulin ratio and cognitive function in American older people: a cross-sectional national health and nutrition examination survey 2011–2014 (NHANES) study. Frontiers in Public Health. 2024;Volume 12 - 2024.doi: 10.3389/fpubh.2024.1375379
Williams ME, Naudé PJW. The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue. Reviews in Medical Virology. 2024;34(1):e2519.doi: https://doi.org/10.1002/rmv.2519
McGuire JL, Gill AJ, Douglas SD, Kolson DL, Group CHATER. The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth. Journal of NeuroVirology. 2016;22(6):823-30.doi: 10.1007/s13365-016-0460-5
Tan S, Chen W, Kong G, Wei L, Xie Y. Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications. Frontiers in Aging Neuroscience. 2023;Volume 15 - 2023.doi: 10.3389/fnagi.2023.1305790
Liang N, Nho K, Newman JW, Arnold M, Huynh K, Meikle PJ, et al. Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease. Scientific Reports. 2024;14(1):17423.doi: 10.1038/s41598-024-67177-5
Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61-73.doi: 10.1016/j.ncl.2009.09.004
Qiao S, Li H, Guo F, Cai G, Zhang Y. Research progress on cognitive impairment and the expression of serum inflammatory markers in patients with white matter hyperintensities: a narrative review. Ann Transl Med. 2022;10(7):421.doi: 10.21037/atm-22-1016
Thompson LJ, Genovese J, Hong Z, Singh MV, Singh VB. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology. International Journal of Molecular Sciences [Internet]. 2024; 25(9).doi: 10.3390/ijms25094697
Owens CD, Bonin Pinto C, Mukli P, Szarvas Z, Peterfi A, Detwiler S, et al. Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study. PLOS ONE. 2023;18(8):e0289508.doi: 10.1371/journal.pone.0289508
Li M, Li R, Lyu J-h, Chen J-h, Wang W, Gao M-l, et al. Relationship Between Alzheimer’s Disease and Retinal Choroidal Thickness: A Cross-Sectional Study. Journal of Alzheimer’s Disease. 2021;80(1):407-19.doi: 10.3233/jad-201142
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
